Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity

v3.23.1
Note 10 - Shareholders' Equity
 3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Equity [Text Block]

10.

Shareholders’ Equity

 

Authorized capital stock

 

The Company has authorized share capital of an unlimited number of voting common shares, and the shares do not have a stated par value. Common shareholders are entitled to receive dividends as declared by the Company, if any, and are entitled to one vote per share at the Company's annual general meeting and any special meeting.

 

Equity issued during the three months ended March 31, 2023

 

During the three months ended March 31, 2023, 17,621 common shares were issued in settlement of deferred share units and 4,289 common shares were issued upon the vesting of restricted stock units.

 

Equity issued during the three months ended March 31, 2022

 

During the three months ended March 31, 2022, we did not issue any common shares

 

Shares reserved

 

Common shares reserved for future issuance are as follows:

 

   

March 31, 2023

  

Common shares issuable upon exercise of employee and non-employee stock options

     2,773,498  

Common shares issuable upon settlement of deferred stock units

     213,905  

Common shares issuable upon vesting of restricted stock units

     12,867  

Common shares issuable upon exercise of common share purchase warrants

     265,000  

Shares available for grant under the 2019 Omnibus Incentive Plan

     1,899,730  

Shares available for grant under the 2021 Employment Inducement Incentive Plan

     535,000  

Total

     5,700,000